A multidenominational coalition of shareholders and other concerned investors on Wednesday announced the filing of shareholder resolutions at four major pharmaceutical firms to urge the companies to better respond to the AIDS epidemic around the world, including making treatments affordable in developing countries. During a news conference sponsored by the Interfaith Center on Corporate Responsibility, the coalition announced the filing of resolutions that will be voted on during upcoming annual shareholder meetings for Abbott Laboratories, Merck, Bristol-Myers Squibb, and Pfizer. The resolutions would require the companies to review the economic effects of addressing the AIDS pandemic on each company's business strategy, including the impact of expanding access to anti-HIV medications in poor countries. The coalition has sponsored similar AIDS-related resolutions at other companies such as Caterpillar, ChevronTexaco, Coca-Cola, and PepsiCo, each of which have a significant business presence in countries hard-hit by AIDS.
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Stay up to date with the latest in LGBTQ+ news with The Advocate’s email newsletter, in your inbox five days a week.
@ 2026 Equal Entertainment LLC.
All rights reserved
All rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Latest
Support Independent Journalism
LGBTQ+ stories deserve to betold.
Your membership powers The Advocate's original reporting—stories that inform, protect, and celebrate our community.
Become a Member
FOR AS LITTLE AS $5. CANCEL ANYTIME.
More For You
Most Popular
@ 2026 Equal Entertainment LLC. All Rights reserved















